{"id":"https://openalex.org/W3036387353","doi":"https://doi.org/10.1016/j.bmcl.2020.127363","title":"Corrigendum to \u201cDesign of selective PI3K\u03b4 inhibitors using an iterative scaffold-hopping workflow\u201d [Bioorg. Med. Chem. Lett. 29 (2019) 2575\u20132580]","display_name":"Corrigendum to \u201cDesign of selective PI3K\u03b4 inhibitors using an iterative scaffold-hopping workflow\u201d [Bioorg. Med. Chem. Lett. 29 (2019) 2575\u20132580]","publication_year":2020,"publication_date":"2020-06-23","ids":{"openalex":"https://openalex.org/W3036387353","doi":"https://doi.org/10.1016/j.bmcl.2020.127363","mag":"3036387353","pmid":"https://pubmed.ncbi.nlm.nih.gov/32591133"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2020.127363","doi":"https://doi.org/10.1016/j.bmcl.2020.127363","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2020.127363","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"erratum","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043807280","display_name":"Xavier Fradera","orcid":"https://orcid.org/0000-0002-6118-075X","observed_orcids":["https://orcid.org/0000-0002-6118-075X"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Xavier Fradera","raw_affiliation_strings":["Computational and Structural Chemistry, Merck & Co., Inc., Boston, MA, USA. Electronic address: xavier.fradera@merck.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Computational and Structural Chemistry, Merck & Co., Inc., Boston, MA, USA. Electronic address: xavier.fradera@merck.com","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047497239","display_name":"Joey L. Methot","orcid":"https://orcid.org/0000-0003-3374-181X","observed_orcids":["https://orcid.org/0000-0003-3374-181X"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joey L. Methot","raw_affiliation_strings":["Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035542081","display_name":"Abdelghani Achab","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abdelghani Achab","raw_affiliation_strings":["Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Matthew Christopher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Christopher","raw_affiliation_strings":["Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081682934","display_name":"Michael D. Altman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael D. Altman","raw_affiliation_strings":["Computational and Structural Chemistry, Merck & Co., Inc., Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Computational and Structural Chemistry, Merck & Co., Inc., Boston, MA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040526199","display_name":"Hua Zhou","orcid":"https://orcid.org/0000-0003-1822-1306","observed_orcids":["https://orcid.org/0000-0003-1822-1306"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hua Zhou","raw_affiliation_strings":["Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000008133","display_name":"Meredeth A. McGowan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meredeth A. McGowan","raw_affiliation_strings":["Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023200074","display_name":"Solomon D. Kattar","orcid":"https://orcid.org/0000-0002-5527-3626","observed_orcids":["https://orcid.org/0000-0002-5527-3626"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sam D. Kattar","raw_affiliation_strings":["Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103152453","display_name":"Kevin J. Wilson","orcid":"https://orcid.org/0000-0003-4574-8250","observed_orcids":["https://orcid.org/0000-0003-4574-8250"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin Wilson","raw_affiliation_strings":["Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064064978","display_name":"Yudith Garcia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yudith Garcia","raw_affiliation_strings":["Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088744518","display_name":"Martin A. Augustin","orcid":"https://orcid.org/0000-0003-1464-3050","observed_orcids":["https://orcid.org/0000-0003-1464-3050"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin A. Augustin","raw_affiliation_strings":["Proteros Biostructures GmbH, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Proteros Biostructures GmbH, Martinsried, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007820143","display_name":"Charles A. Lesburg","orcid":"https://orcid.org/0000-0001-7245-7331","observed_orcids":["https://orcid.org/0000-0001-7245-7331"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles A. Lesburg","raw_affiliation_strings":["Computational and Structural Chemistry, Merck & Co., Inc., Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Computational and Structural Chemistry, Merck & Co., Inc., Boston, MA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112829846","display_name":"Sanjiv Shah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sanjiv Shah","raw_affiliation_strings":["In vitro Pharmacology, Merck & Co., Inc., Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"In vitro Pharmacology, Merck & Co., Inc., Boston, MA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059885355","display_name":"Peter Goldenblatt","orcid":"https://orcid.org/0000-0002-6328-4253","observed_orcids":["https://orcid.org/0000-0002-6328-4253"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Goldenblatt","raw_affiliation_strings":["In vitro Pharmacology, Merck & Co., Inc., Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"In vitro Pharmacology, Merck & Co., Inc., Boston, MA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052803577","display_name":"Jason D. Katz","orcid":"https://orcid.org/0009-0006-8080-9409","observed_orcids":["https://orcid.org/0009-0006-8080-9409"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason D. Katz","raw_affiliation_strings":["Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5043807280"],"corresponding_institution_ids":["https://openalex.org/I1285764155"],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"30","issue":"16","first_page":"127363","last_page":"127363"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.48489999771118164,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.48489999771118164,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.46309998631477356,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.006399999838322401,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pi3kdelta-inhibitor","display_name":"PI3K\u03b4 inhibitor","score":0.9879999756813049},{"id":"https://openalex.org/keywords/selective-kinase-inhibitors","display_name":"selective kinase inhibitors","score":0.6880000233650208},{"id":"https://openalex.org/keywords/scaffold-hopping","display_name":"scaffold hopping","score":0.9860000014305115},{"id":"https://openalex.org/keywords/iterative-design","display_name":"iterative design","score":0.4020000100135803},{"id":"https://openalex.org/keywords/drug-design","display_name":"drug design","score":0.39899998903274536}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8492081761360168},{"id":"https://openalex.org/C177212765","wikidata":"https://www.wikidata.org/wiki/Q627335","display_name":"Workflow","level":2,"score":0.599394679069519},{"id":"https://openalex.org/C89429830","wikidata":"https://www.wikidata.org/wiki/Q735710","display_name":"Scaffold","level":2,"score":0.5082904696464539},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.48455730080604553},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.1298467516899109},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.11216104030609131},{"id":"https://openalex.org/C77088390","wikidata":"https://www.wikidata.org/wiki/Q8513","display_name":"Database","level":1,"score":0.05036276578903198}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.bmcl.2020.127363","doi":"https://doi.org/10.1016/j.bmcl.2020.127363","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2020.127363","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:32591133","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32591133","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Published Erratum"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2964489299","https://openalex.org/W6945195048","https://openalex.org/W2911281784","https://openalex.org/W3153170011","https://openalex.org/W2191281559","https://openalex.org/W2999377677","https://openalex.org/W2886799741","https://openalex.org/W6945199930","https://openalex.org/W4362677258","https://openalex.org/W2490393442"],"abstract_inverted_index":null,"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2020-06-25T00:00:00"}